Mouse Anti-HNRNPK Recombinant Antibody (A254) (CBMAB-AP2972LY)

Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Negative regulation of apoptotic process Source: MGI
Negative regulation of mRNA splicing, via spliceosome Source: Ensembl
Negative regulation of transcription, DNA-templated Source: UniProtKB
Positive regulation of low-density lipoprotein receptor activity Source: BHF-UCL
Positive regulation of receptor-mediated endocytosis Source: BHF-UCL
Positive regulation of transcription by RNA polymerase II Source: Ensembl
Regulation of gene expression Source: GO_Central
Regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator Source: Ensembl
Regulation of low-density lipoprotein particle clearance Source: BHF-UCL
Regulation of mRNA splicing, via spliceosome Source: GO_Central
Regulation of transcription by RNA polymerase II Source: GO_Central
RNA processing Source: ProtInc
Signal transduction Source: ProtInc
A disorder characterized by intellectual disability, facial dysmorphism, cardiac defects, and connective tissue and skeletal abnormalities. Dysmorphic features include long palpebral fissures, ptosis, a broad prominent nasal bridge, hypoplastic alae nasi, an open downturned mouth, ears with underdeveloped and thick helices, high palate, and a unique tongue with a prominent median crease. Hypotonia, hyporeflexia, and high pain tolerance are additional features.
Sumoylated by CBX4. Sumoylation is increased upon DNA damage, such as that produced by doxorubicin, etoposide, UV light and camptothecin, due to enhanced CBX4 phosphorylation by HIPK2 under these conditions.
Ubiquitinated by MDM2. Doxorubicin treatment does not affect monoubiquitination, but slightly decreases HNRNPK poly-ubiquitination.
O-glycosylated (O-GlcNAcylated), in a cell cycle-dependent manner.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols
Related Products
Recombinant Mouse Anti-HNRNPK Recombinant Antibody (N10 P2D3) (CAT#: CBMAB-XB0557-YC)
Rabbit Anti-HNRNPK Recombinant Antibody (CBNH-070) (CAT#: CBMAB-R4395-CN)
Mouse Anti-HNRNPK (C-terminus) Monoclonal Antibody (CBFYH-3183) (CAT#: CBMAB-H0256-FY)
Mouse Anti-HNRNPK Recombinant Antibody (CBFYH-1655) (CAT#: CBMAB-H2661-FY)
Rabbit Anti-HNRNPK Recombinant Antibody (EG1534) (CAT#: CBMAB-EN1833-LY)
Mouse Anti-HNRNPK Recombinant Antibody (CBYJT-1378) (CAT#: CBMAB-T0400-YJ)
Mouse Anti-HNRNPK Recombinant Antibody (F45 P9 C7) (CAT#: CBMAB-H2655-FY)
Mouse Anti-HNRNPK Recombinant Antibody (CBFYH-1650) (CAT#: CBMAB-H2657-FY)
Mouse Anti-HNRNPK Recombinant Antibody (CBFYH-1657) (CAT#: CBMAB-H2663-FY)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
